ORD_464985/2023 | EP3056563B1 | UPC Decision Search

	Type Order Decision	Reference	Court Division Brüssel Brussels Copenhagen Den Haag Düsseldorf Hamburg Helsinki Lisbon Lissabon Luxembourg Luxemburg Mailand Mannheim Milan München Munich Nordic Baltic Regional Division Paris The Hague Vienna			Tags
16 June, 2023	Order	ORD_464985/2023	Paris (FR) Central D…	EP3056563B1	Rule 17.3 RoP ...	Please log in to add tags.	Please log in to add notes. Please log in to add tags. Show on UPC ORD_464985/2023 UPC_CFI_75_2023 16 June, 2023 Order Summary (AI generated) Parties ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE v. HEALIOS K.K, RIKEN, OSAKA UNIVERSITY Registry Information Court Division: Paris (FR) Central Division - Seat Type of Action: Revocation Action Language of Proceedings: EN Patent at issue EP3056563B1 Cited Legal Standards R.17.3 RoP R.345.3 RoP R.47 RoP Rule 17.3 RoP Rule 345.3 Rule 345.3. Documents Download Order (EN) Add a custom note or summary to this decision Styles Text Heading 1 Heading 2 Heading 3 Bold ⌘B Italic ⌘I Strikethrough ⌘+Shift+S Bullet list Ordered list Blockquote ⌘+Shift+B Insert link ⌘K Insert link Unlink Align Left Center Right No. ACT_464985/2023 UPC_CFI_75/2023 Revocation action ORDER (Rule 17.3 RoP) Of the Court of First Instance of the Unified Patent Court Central Division (Paris Seat) Issued on 16 June 2023 concerning EP No. EP 3056563 B1 CLAIMANT: ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE 251 Little Falls Drive, Wilmington, Delaware, US 19808 Represented by Potter Clarkson LLP. DEFENDANTS: HEALIOS K.K - 4-1, Hamamatsu-cho 2-chome Minato-ku Tokyo 105-6115, Japan RIKEN 2-1, Hirosawa Wako-shi, Saitama 351-0198, Japan OSAKA UNIVERSITY - 1-1 Yamadaoka Suita-shi, Osaka 565- 0871, Japan. PATENT AT ISSUE: No. EP 3056563 B1 PANEL/DIVISION: Panel 1 of the Central Division (Paris Seat) This order has been issued by the presiding judge of panel 1. SUMMARY OF FACTS On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of the European Patent No. EP 3056563 B1 entitled 'method of producing retinal pigment epithelial cell' before the Central Division of the UPC against the concerned registered proprietors, namely HEALIOS KK, RIKEN and OSAKA UNIVERSITY. GROUNDS FOR THE ORDER Pursuant R.17.3 RoP, 'the following shall determine the distribution of actions between the seat of the central division and its sections. (a) Where an action involves a single patent having a single classification, the Registry shall allocate the action to the seat or the section of the central division appropriate to the classification of the patent according to Annex II of the Agreement. The Registry shall assign the action to a panel in accordance with Rule 345.3. (b) Where an action involves more than one patent and a majority of the patents have a single classification appropriate to the seat or a single section of the central division according to Annex II of the Agreement, the Registry shall allocate the action to the seat or that section of the central division. The Registry shall assign the action to a panel in accordance with Rule 345.3. (c) Where neither paragraph (a) nor (b) applies, especially where (i) the action involves a single patent having more than one classification or (ii) where the action involves more than one patent and no majority of the patents have a single classification corresponding to the seat or to one of the sections of the central division, the Registry shall assign the action in accordance with Rule 345.3 to the panel at the seat or the section appropriate to the first classification of either the single patent or, where the action involves more than one patent, the patent first listed in the Statement of claim, according to Annex II of the Agreement. If the presiding judge of the respective panel considers that the reference of the action is appropriate, he shall accept it. If he considers otherwise, he shall instruct the Registry to refer the action in accordance with Rule 345.3 to the presiding judge of a panel of either the seat or the other section of the central division he considers appropriate, who shall likewise consider whether the re- allocation of the action is appropriate. If that presiding judge considers otherwise, he shall inform the President of the Court of First Instance, who shall allocate the action to the seat or the section of the central division he considers appropriate'. Pursuant R.47 RoP, R.16 to R.18 shall apply mutatis mutandis to the statement for Revocation. By decision No. PR/08052023 dated 8 May 2023, the Presidium of the UPC as being responsible for the management of the court pursuant art 15(3) UPCS, determined provisionally the distribution of actions related to patents in IPC sections (A) and (C) pending before the central division in the context of the Withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union as follows : actions pending before the central division related to patents in IPC section (A) shall be assigned to the seat in Paris (art.1). actions pending before the central division related to patents in IPC section (C) shall be assigned to the section in Munich (art.2). This decision entered into force on 1 June 2023 is applicable until the establishment of a further section of the Central Division of the Unified Patent Court. The first classification mentioned by the patent at issue is C 12N 5/10. Pursuant R.17.3 abovementioned, the action shall therefore be re-allocated to the Central Division - Munich section. FOR THESE GROUNDS The Registry is instructed to refer the action in accordance with R.345.3 RoP to the Presiding Judge of the relevant panel of the Central Division-Munich Section. ORDER Issued on 16 June 2023 NAMES AND SIGNATURES Presiding Judge of Panel 1 Central Division (Paris seat) Florence Butin

ORD_464985/2023

No. ACT_464985/2023 UPC_CFI_75/2023

Revocation action

ORDER (Rule 17.3 RoP)

Of the Court of First Instance of the Unified Patent Court Central Division (Paris Seat) Issued on 16 June 2023 concerning EP No. EP 3056563 B1

CLAIMANT:

ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE

251 Little Falls Drive, Wilmington, Delaware, US 19808 Represented by Potter Clarkson LLP.

DEFENDANTS:

HEALIOS K.K - 4-1, Hamamatsu-cho 2-chome Minato-ku Tokyo 105-6115, Japan

RIKEN

2-1, Hirosawa Wako-shi,

Saitama 351-0198, Japan

OSAKA UNIVERSITY - 1-1 Yamadaoka Suita-shi,

Osaka 565- 0871, Japan.

PATENT AT ISSUE:

No. EP 3056563 B1

PANEL/DIVISION:

Panel 1 of the Central Division (Paris Seat)

This order has been issued by the presiding judge of panel 1.

SUMMARY OF FACTS

On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of the European Patent No. EP 3056563 B1 entitled 'method of producing retinal pigment epithelial cell' before the Central Division of the UPC against the concerned registered proprietors, namely HEALIOS KK, RIKEN and OSAKA UNIVERSITY.

GROUNDS FOR THE ORDER

Pursuant R.17.3 RoP, 'the following shall determine the distribution of actions between the seat of the central division and its sections.

(a) Where an action involves a single patent having a single classification, the Registry shall allocate the action to the seat or the section of the central division appropriate to the classification of the patent according to Annex II of the Agreement. The Registry shall assign the action to a panel in accordance with Rule 345.3.
(b) Where an action involves more than one patent and a majority of the patents have a single classification appropriate to the seat or a single section of the central division according to Annex II of the Agreement, the Registry shall allocate the action to the seat or that section of the central division.
The Registry shall assign the action to a panel in accordance with Rule 345.3.
(c) Where neither paragraph (a) nor (b) applies, especially where
(i) the action involves a single patent having more than one classification or
(ii) where the action involves more than one patent and no majority of the patents have a single classification corresponding to the seat or to one of the sections of the central division, the Registry shall assign the action in accordance with Rule 345.3 to the panel at the seat or the section appropriate to the first classification of either the single patent or, where the action involves more than one patent, the patent first listed in the Statement of claim, according to Annex II of the Agreement. If the presiding judge of the respective panel considers that the reference of the action is appropriate, he shall accept it. If he considers otherwise, he shall instruct the Registry to refer the action in accordance with Rule 345.3 to the presiding judge of a panel of either the seat or the other section of the central division he considers appropriate, who shall likewise consider whether the re- allocation of the action is appropriate. If that presiding judge considers otherwise, he shall inform the President of the Court of First Instance, who shall allocate the action to the seat or the section of the central division he considers appropriate'.

Pursuant R.47 RoP, R.16 to R.18 shall apply mutatis mutandis to the statement for Revocation.

By decision No. PR/08052023 dated 8 May 2023, the Presidium of the UPC as being responsible for the management of the court pursuant art 15(3) UPCS, determined provisionally the distribution of actions related to patents in IPC sections (A) and (C) pending before the central division in the context of the Withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union as follows :

- actions pending before the central division related to patents in IPC section (A) shall be assigned to the seat in Paris (art.1).
- actions pending before the central division related to patents in IPC section (C) shall be assigned to the section in Munich (art.2).

This decision entered into force on 1 June 2023 is applicable until the establishment of a further section of the Central Division of the Unified Patent Court.

The first classification mentioned by the patent at issue is C 12N 5/10.

Pursuant R.17.3 abovementioned, the action shall therefore be re-allocated to the Central Division - Munich section.

FOR THESE GROUNDS

The Registry is instructed to refer the action in accordance with R.345.3 RoP to the Presiding Judge of the relevant panel of the Central Division-Munich Section.

ORDER

Issued on 16 June 2023

NAMES AND SIGNATURES

Presiding Judge of Panel 1 Central Division (Paris seat) Florence Butin

ORD_464985/2023